BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 24878218)

  • 21. Decrease in microvesicle-associated tissue factor activity in morbidly obese patients after bariatric surgery.
    Ay L; Thaler J; Brix JM; Schernthaner GH; Ay C; Pabinger I; Schernthaner G
    Int J Obes (Lond); 2016 May; 40(5):768-72. PubMed ID: 26620889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and adipocytokine changes after bariatric surgery in morbidly obese women.
    Auguet T; Terra X; Hernández M; Sabench F; Porras JA; Orellana-Gavaldà JM; Llutart J; Guiu-Jurado E; Berlanga A; Martinez S; Aguilar C; Castillo DD; Richart C
    Obesity (Silver Spring); 2014 Jan; 22(1):188-94. PubMed ID: 23554365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Soluble intercellular adhesion molecule-1 and C reactive protein after bariatric surgery].
    Orea Soler I; Illán Gómez F; Gonzálvez Ortega M; Alcaraz Tafalla MS; Pérez Paredes M; Lozano Almela ML; Pascual Saura MH; Pascual Díaz M
    Endocrinol Nutr; 2010 Mar; 57(3):90-4. PubMed ID: 20303837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of bariatric surgery on airway response and lung function in obese subjects with asthma.
    Boulet LP; Turcotte H; Martin J; Poirier P
    Respir Med; 2012 May; 106(5):651-60. PubMed ID: 22326605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of circulating proinflammatory marker, leucine-rich-α2-glycoprotein (LRG1), following metabolic/bariatric surgery.
    Pek SLT; Cheng AKS; Lin MX; Wong MS; Chan EZL; Moh AMC; Sum CF; Lim SC; Tavintharan S
    Diabetes Metab Res Rev; 2018 Oct; 34(7):e3029. PubMed ID: 29883055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of C-reactive protein after surgery for obesity and metabolic disorders.
    Chiappetta S; Jamadar P; Stier C; Bottino V; Weiner RA; Runkel N
    Surg Obes Relat Dis; 2020 Jan; 16(1):99-108. PubMed ID: 31784329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum leptin levels after bariatric surgery across a range of glucose tolerance from normal to diabetes.
    Geloneze B; Tambascia MA; Pareja JC; Repetto EM; Magna LA; Pereira SG
    Obes Surg; 2001 Dec; 11(6):693-8. PubMed ID: 11775566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of a rapid weight loss induced by laparoscopic adjustable gastric banding on arterial stiffness, metabolic and inflammatory parameters in patients with morbid obesity.
    Shargorodsky M; Fleed A; Boaz M; Gavish D; Zimlichman R
    Int J Obes (Lond); 2006 Nov; 30(11):1632-8. PubMed ID: 16552402
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advanced glycation end-products in morbid obesity and after bariatric surgery: When glycemic memory starts to fail.
    Sánchez E; Baena-Fustegueras JA; de la Fuente MC; Gutiérrez L; Bueno M; Ros S; Lecube A
    Endocrinol Diabetes Nutr; 2017 Jan; 64(1):4-10. PubMed ID: 28440769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of surgically-induced weight loss on inflammatory mediators and peripheral blood monocyte CD11b expression in morbid obesity.
    Sabri AA; Reda R; Ali AA; Abdel Alim A; Bakr SI; Abo-Shady RA; Mohamed HG; Saleh R
    Egypt J Immunol; 2010; 17(1):19-28. PubMed ID: 22053606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum bile acid along with plasma incretins and serum high-molecular weight adiponectin levels are increased after bariatric surgery.
    Nakatani H; Kasama K; Oshiro T; Watanabe M; Hirose H; Itoh H
    Metabolism; 2009 Oct; 58(10):1400-7. PubMed ID: 19570554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improvement of atherosclerotic markers in non-diabetic patients after bariatric surgery.
    Saleh MH; Bertolami MC; Assef JE; Taha MI; de Freitas W; Petisco AC; Barretto RB; Le Bihan DC; Barbosa JE; de Jesus CA; Sousa AG
    Obes Surg; 2012 Nov; 22(11):1701-7. PubMed ID: 22777211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of bariatric surgery on liver glucose metabolism in morbidly obese diabetic and non-diabetic patients.
    Immonen H; Hannukainen JC; Iozzo P; Soinio M; Salminen P; Saunavaara V; Borra R; Parkkola R; Mari A; Lehtimäki T; Pham T; Laine J; Kärjä V; Pihlajamäki J; Nelimarkka L; Nuutila P
    J Hepatol; 2014 Feb; 60(2):377-83. PubMed ID: 24060855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Laparoscopic bariatric surgery for those with body mass index of 70-125 kg/m2.
    Eldar SM; Heneghan HM; Brethauer SA; Khwaja HA; Singh M; Rogula T; Schauer PR
    Surg Obes Relat Dis; 2012; 8(6):736-40. PubMed ID: 22093378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcome following bariatric surgery in super versus morbidly obese patients: does weight matter?
    Bloomston M; Zervos EE; Camps MA; Goode SE; Rosemurgy AS
    Obes Surg; 1997 Oct; 7(5):414-9. PubMed ID: 9730495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors of dropout and bariatric surgery in Icelandic morbidly obese female patients.
    Benediktsdottir A; Halldorsson TI; Bragadottir GJ; Gudmundsson L; Ramel A
    Obes Res Clin Pract; 2016; 10(1):63-9. PubMed ID: 25892541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Soluble CD40 ligand in morbidly obese patients: effect of body mass index on recovery to normal levels after gastric bypass surgery.
    Baena-Fustegueras JA; Pardina E; Balada E; Ferrer R; Catalán R; Rivero J; Casals I; Lecube A; Fort JM; Vargas V; Peinado-Onsurbe J
    JAMA Surg; 2013 Feb; 148(2):151-6. PubMed ID: 23426590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [EVALUATION OF A COMPREHENSIVE PROGRAM OF FOUR MONTHS OF DURATION ON THE PREOPERATIVE CONDITIONS OF OBESE PATIENTS CANDIDATES FOR BARIATRIC SURGERY].
    Delgado Floody P; Cofré Lizama A; Alarcón Hormazábal M; Osorio Poblete A; Caamaño Navarrete F; Jerez Mayorga D
    Nutr Hosp; 2015 Sep; 32(3):1022-7. PubMed ID: 26319815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of bariatric surgery on gout: a comparative study.
    Romero-Talamás H; Daigle CR; Aminian A; Corcelles R; Brethauer SA; Schauer PR
    Surg Obes Relat Dis; 2014; 10(6):1161-5. PubMed ID: 24935177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduction of risk factors for cardiovascular diseases in morbid-obese patients following biliary-intestinal bypass: 3 years' follow-up.
    Lubrano C; Cornoldi A; Pili M; Falcone S; Brandetti F; Fabbrini E; Ginanni-Corradini S; Eramo A; Marini M; Migliaccio S; Giancotti V; Badiali M; Falsetto N; Prossomariti G; Spera G
    Int J Obes Relat Metab Disord; 2004 Dec; 28(12):1600-6. PubMed ID: 15543161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.